Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03102385
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
OIC | OCTAHYDROINDOLE-2-CARBOXYLIC ACID | B,C | 3BV9 | 0.85 | |
OIC | OCTAHYDROINDOLE-2-CARBOXYLIC ACID | A | 1BDK | 0.85 | |
LY5 | (3S,4aR,6S,8aR)-6-{[(2S)-2-carboxy- 4,4-difluoropyrrolidin-1-yl]methyl}decahydroisoquinoline- 3-carboxylic acid | A,B,C,D | 2QS4 | 0.75 | |
BB2 | ACTINONIN | A,B,C,D | 3G5K | 0.76 | |
BB2 | ACTINONIN | A,B,C | 1LRU | 0.76 | |
BB2 | ACTINONIN | A,B | 2OKL | 0.76 | |
BB2 | ACTINONIN | A | 2OS1 | 0.76 | |
BB2 | ACTINONIN | A,B,C | 1G2A | 0.76 | |
BB2 | ACTINONIN | A | 1Q1Y | 0.76 | |
BB2 | ACTINONIN | A,B,C,D,E,F, G,H | 1SZZ | 0.76 | |
BB2 | ACTINONIN | A | 1LQY | 0.76 | |
BB2 | ACTINONIN | A | 2OS3 | 0.76 | |
BB2 | ACTINONIN | A | 1LRY | 0.76 | |
BB2 | ACTINONIN | A,B | 1IX1 | 0.76 | |
BB2 | ACTINONIN | A | 1WS1 | 0.76 | |
074 | [PROPYLAMINO-3-HYDROXY-BUTAN-1,4- DIONYL]-ISOLEUCYL-PROLINE | A | 1QDQ | 0.72 | |
AMK | (S)-4-AMINO-4-{(S)-1-[(S)-2-CARBAMOYL- 1-((S)-1-{(S)-[(1R,2R)-2-((S)-1- CARBOXY-ETHYLCARBAMOYL)-CYCLOPENTYL]- HYDROXY-METHYL}-3-METHYL-BUTYLCARBAMOYL)- ETHYLCARBAMOYL]-2-METHYL-PROPYLCARBAMOYL}- BUTYRIC ACID | A,B,C | 1YM4 | 0.73 | |
REZ | (2R)-2-AMINO-7-{[(1R)-1-CARBOXYETHYL]AMINO}- 7-OXOHEPTANOIC ACID | A,B | 2J9P | 0.73 | |
REZ | (2R)-2-AMINO-7-{[(1R)-1-CARBOXYETHYL]AMINO}- 7-OXOHEPTANOIC ACID | A,B,C,D | 2VGK | 0.73 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 2BJS | 0.73 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 1QJE | 0.73 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 1BK0 | 0.73 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 1BLZ | 0.73 | |
O12 | N~5~-dodecanoyl-L-ornithine | A,B,C,D,E,F, G,H,I,J,K,L | 3CAY | 0.72 | |
O12 | N~5~-dodecanoyl-L-ornithine | A,B,C,D,E,F, G,H,I,J,K,L | 3CBA | 0.72 | |
RPH | 6-HYDROXO-OCTAHYDRO-INDOLE-2-CARBALDEHYDE | H,I | 1A2C | 0.73 | |
ABX | 5-[1-(ACETYLAMINO)-3-METHYLBUTYL]- 4-(METHOXYCARBONYL)PROLINE | A | 1XOE | 0.8 | |
UZ9 | (2S)-2-AMINO-6-({(4R)-4-[(10R,13S)- 10,13-DIMETHYL-3-OXOHEXADECAHYDRO- 1H-CYCLOPENTA[A]PHENANTHREN-17- YL]PENTANOYL}AMINO)HEXANOIC ACID | A,B | 1UZ9 | 0.7 | |
AR9 | (2R,4S)-N-butyl-4-[(2S,5S,7R)-2,7- dimethyl-3,15-dioxo-1,4-diazacyclopentadecan- 5-yl]-4-hydroxy-2-methylbutanamide | A,B,C | 3DV1 | 0.75 | |
REX | GLYCYL-L-ALPHA-AMINO-EPSILON-PIMELYL- D-ALANYL-D-ALANINE | A | 1IKG | 0.75 | |
ITL | (3alpha,5alpha,8alpha)-3-[(N,N- bis{2-[bis(carboxymethyl)amino]ethyl}- L-gamma-glutamyl)amino]cholan-24- oic acid | A | 2K62 | 0.75 | |
SSC | (2S,5S)-5-CARBOXYMETHYLPROLINE | A,B,C,D | 1Q19 | 0.7 | |
BCV | D-(L-A-AMINOADIPOYL)-L-CYSTEINYL- D-CYCLOPROPYLGLYCINE | A | 2IVJ | 0.7 | |
REY | GLYCYL-L-ALPHA-AMINO-EPSILON-PIMELYL- D-ALANINE | A | 1IKI | 0.76 |